Mounjaro®
Starting from £179.99/mo
Start journey Learn moreRapid weight loss can change how your face and body look, and some people on tirzepatide notice their skin sitting differently after significant loss. Mounjaro itself does not accelerate biological ageing — the visible changes are driven by fat redistribution, not by the medicine acting on your skin or collagen directly. Understanding the sequence of events helps you make sense of what you might see in the mirror. As a prescription-only medicine, tirzepatide requires clinical assessment before it can be prescribed, and a qualified prescriber can talk through any cosmetic concerns as part of that process.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Fat is distributed throughout the body, including in the small pockets that give your cheeks, temples and under-eye area their rounded, supported look. When overall body fat falls, facial fat falls too. There is no mechanism by which tirzepatide targets skin collagen, accelerates cellular ageing or degrades elastin, those concerns are not supported by the clinical trial data or by the pharmacology of a GLP-1/GIP receptor agonist.
What tirzepatide does is reduce appetite meaningfully, which leads some people to lose weight faster than they might on other approaches. Speed matters here. A slow, steady reduction gives skin more time to adapt than a very rapid one. The tirzepatide treatment overview on this site outlines how the titration schedule is designed partly to manage tolerance, and that gradual approach tends to produce a more measured rate of loss than crash dieting.
The colloquial phrase 'Ozempic face' emerged from social media observations about facial hollowing in people on semaglutide-based treatments. The same mechanism applies to any significant weight loss, regardless of how it is achieved. It is not unique to GLP-1 medicines. The NHS notes that facial changes after weight loss reflect fat redistribution rather than skin damage, and the NHS tirzepatide medicines page does not list accelerated ageing or skin deterioration among the known effects of the drug.
Muscle sits underneath skin and contributes to the firm, filled-out appearance most people associate with looking healthy rather than drawn. When calorie intake drops sharply without enough protein or resistance activity, the body can break down muscle alongside fat. This loss of muscle mass, called sarcopenia in its extreme form, is a legitimate concern with any significant weight-loss programme.
The practical response is straightforward: prioritise protein at every meal (many prescribers suggest aiming for around 1.2–1.6 g per kilogram of body weight, though personal targets depend on your full health picture), and include resistance-based exercise two to three times a week. Your prescriber and, where relevant, a dietitian can help you set appropriate targets. There is also a separate but related question about how hormonal factors interact with body composition during treatment, people curious about that intersection can read more on the tirzepatide and testosterone replacement therapy page.
Adequate hydration supports skin elasticity too. This is easy to overlook when appetite suppression is strong and you are eating and drinking less overall, and some people also notice feeling colder than usual as their body adjusts to eating less, which can be another subtle sign that energy balance has shifted. Dehydration makes skin appear duller and fine lines more pronounced, a reversible effect, but one worth staying on top of day to day.
Once a meaningful amount of weight has been lost, some degree of loose skin is common. How much depends on the amount lost, the speed of loss, age, genetics and how well skin elasticity has been maintained. For most people who lose weight gradually and support the process with nutrition and activity, the skin adapts over months. Dramatic laxity requiring intervention tends to follow very large or very rapid losses.
Skin care during treatment is largely common sense: sun protection slows collagen degradation; moisturising regularly maintains the skin barrier; avoiding smoking preserves elasticity. None of these are specific to tirzepatide; they apply to any significant weight-loss journey.
If concerns about appearance are affecting your confidence or decision-making around treatment, that is worth raising directly with your prescriber rather than dismissing. A good clinical consultation covers more than BMI numbers. The page on whether Mounjaro accelerates ageing goes into more detail on the biological mechanisms, and the overview of how Mounjaro affects your appearance covers body composition changes more broadly.
Thinking about the cost side of treatment? The Mounjaro pricing page sets out what private prescriptions typically involve and what a transparent service price should include.
A few conversations are worth having before you begin and as treatment progresses. First, be honest about your starting point: skin quality, any existing nutritional deficiencies and activity levels all affect how your body responds to weight loss. Second, ask specifically about titration pace, there is no obligation to push to the highest dose as quickly as possible, and a slower climb gives your body more time to adjust. Third, flag any changes you notice early rather than waiting for a review appointment.
Some people find their concerns peak in the first few months, then resolve as skin adapts and muscle is rebuilt. Others notice improvements in how they look overall as the metabolic and cardiovascular benefits of healthier weight take hold. The picture is rarely simple, which is why these questions belong in a clinical conversation.
At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber, not passed through automated screening. If you have questions about how treatment might suit your situation, check your eligibility and start a free consultation today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.